Viral hepatitis infection and insulin resistance: A review of the pathophysiological mechanisms

Salud Publica de Mexico

Volumn 53, Issue SUPPL. 1, 2011, Pages

  Gutiérrez Grobe, Ylse ^a   Ponciano Rodríguez, Guadalupe ^b   Méndez Sánchez, Nahum ^a  

^a Unidad de Terapia Intensiva   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Hepatitis B virus; Hepatitis C virus; Insulin resistance

Indexed keywords

CYTOKINE; FATTY ACID; FRUCTOSE 2,6 BISPHOSPHATE; FRUCTOSE 2,6-DIPHOSPHATE; FRUCTOSE BISPHOSPHATE; VIRUS PROTEIN;

ADULT; AGED; BIOSYNTHESIS; COMORBIDITY; ENERGY METABOLISM; GENOTYPE; GLUCONEOGENESIS; HUMAN; INSULIN RESISTANCE; LIVER DISEASE; METABOLISM; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; SECRETION; VIRUS HEPATITIS;

ADULT; AGED; COMORBIDITY; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS; FRUCTOSEDIPHOSPHATES; GENOTYPE; GLUCONEOGENESIS; HEPATITIS, VIRAL, HUMAN; HUMANS; INSULIN RESISTANCE; LIVER DISEASES; MEXICO; MIDDLE AGED; OVERWEIGHT; PREVALENCE; RISK FACTORS; VIRAL PROTEINS;

EID: 84855376759     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. th ed., 2005, New York, EU:1825-1855.
2. Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med 2007;120:829-834.
3. Secretaría de Salud. CENAVECE Epidemiología. Anuario de morbilidad 1984-2008. Available at: http://www.dgepi.salud.gob.mx/anuario/html/anuarios.html. [Consulted: July 15th 2010].
4. Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005;4:52-55.
5. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol or cholestatic disease. J Hepatol 2000;32:209-217.
6. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008;134:416-423.
7. Lecube A, Hernández C, Genesca J, et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection. Diabetes Care 2004;27:1171-1175.
8. Arao M, Murase K, Kusakabe A, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003;38:355-360.
9. Singal AK, Ayoola AE. Prevalence and factors affecting occurrence of type 2 diabetes mellitus in Saudi patients with chronic liver disease. Saudi J Gastroenterol 2008;14:118-121.
10. Kobashi-Margáin RA, Gutiérrez-Grobe Y, Uribe M, Ponciano-Rodríguez G, Méndez-Sánchez N. Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. Ann Hepatol 2010; 9: 282-288.
11. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schatner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infections. Mayo Clinic Proc 2000; 75:355-359.
12. Méndez-Sánchez N, Chávez-Tapia NC, Zamora-Valdés D, et al. Hepatobiliary diseases and insulin resistance. Curr Med Chem 2007;14:1988-1999.
13. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, et al. Liver enzymes, the metabolic syndrome, and incident diabetes. Diabetes Care, 28: 1757-1762.
14. Holstein A, Hize S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002; 17: 677-681.
15. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009; 8:13-20.
16. Sindelar DK, Chu CA, Rohlie M, et al. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 1997;46:187-196.
17. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001;50;810-816.
18. Lam TK, Yoshii H, Haber CA, et al. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Edocrinol Metab 2002;283:E682-E691.
19. Wu C, Khan SA, Peng LJ, et al. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab 2006;291:E536-E543.
20. World Health Organization. Hepatitis C: 2008. Available at: http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html. [Consulted: July 15th 2010].
21. Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-816.
22. Machado MV, Cortez-Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol 2009;8:Supplement:S67-S75.
23. Chen HF, Li CY, Chen P, See TT, Lee HY. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006;69:146-152.
24. Allison ME, Wreightt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in cirrhotic population. J Hepatol 1994;21:1135-1139.
25. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-333.
26. Antonelli A, Ferri C, Fallahi P, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005;28:2548-2550.
27. Lecube A, Hernández C, Genescá J. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care 2004;27:2669-2675.
28. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996;32:526-530.
29. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-599.
30. Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus downregulates insulin receptor substrates 1 and 2 up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165:1499-1508.
31. Del Campo JA, Romero-Gómez M. Steatosis and insulin resistance in hepatitis C: A way out of the virus? World J Gastroenterol 2009;15:5016-5019.
32. Pazienza V, Clement S, Pugnale P, et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007;45:1164-1171.
33. Te H, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liv Dis 2010;14:1-21.
34. Custro N, Carroccio A, Ganci A, et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001;1:476-481.
35. Kumar M, Choudhury A, Manglik N, et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol 2009;104:76-82.
36. Wang CC, Hsu CS, Liu CJ, et al. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008;23:779-782.
37. Jas CF, Chen CJ, Chiu YH, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung community-based integrated screening study, 10). Int J Obes 2006;30:794-799.
38. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in Chinese population. Clin Chim Acta 2007;380:238-240.
39. Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR gamma. Gastroenterol 2007,132:1955-1967.
40. Bihl F, Negro F. Chronic hepatitis E in the immunosuppressed: A new source of trouble? J Hepatol 2009;50:435-437.
41. Lagiou P, Kuper H, Stuver S, et al. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Nat Can Inst 2000;92:1096-1099.
42. Secretaría de Salud. Sistema nacional de información en salud. [Consulted: July 15th 2010]. Available at: http://sinais.salud.gob.mx/mortalidad.